Thomas Collet

President & CEO at Bilayer Therapeutics - Cambridge, Massachusetts, United States

Thomas Collet's Colleagues at Bilayer Therapeutics
Thomas Collet's Contact Details
HQ
Location
Cambridge,Massachusetts,United States
Company
Bilayer Therapeutics
Thomas Collet's Company Details
Bilayer Therapeutics logo, Bilayer Therapeutics contact details

Bilayer Therapeutics

Cambridge, Massachusetts, United States • 3 Employees
Research

Bilayer Therapeutics is a development-stage company co-founded in 2020 by a team of world-renowned drug development and delivery experts and gastroenterologists to stimulate the body's innate mechanisms for regulating constipation. Led by BL-010, a proprietary bilayer tablet comprised of a naturally occurring bile acid (chenodeoxycholate or CDC) , the company is developing innovative treatments for Chronic Idiopathic Constipation, Irritable Bowel Syndrome with Constipation and other conditions of the colon such as IBD (ulcerative cholitis, Crohn's disease), and diabetes / obesity / metabolic disorders.

Details about Bilayer Therapeutics
Frequently Asked Questions about Thomas Collet
Thomas Collet currently works for Bilayer Therapeutics.
Thomas Collet's role at Bilayer Therapeutics is President & CEO.
Thomas Collet's email address is ***@bilayer-therapeutics.com. To view Thomas Collet's full email address, please signup to ConnectPlex.
Thomas Collet works in the Research industry.
Thomas Collet's colleagues at Bilayer Therapeutics are and others.
Thomas Collet's phone number is
See more information about Thomas Collet